Lisa König

Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy

Lisa König, Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner et al. · OncoImmunology · 2017 · 128 citations · Full text

Extracellular Vesicles, Breast Oncology, Therapy Failure +12

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients

Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann et al. · Human Immunology · 2016 · 82 citations

Vesicular Hla-g, Breast Oncology, Cancer Immunosurveillance +9

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, Lisa König et al. · Breast Cancer Research · 2016 · 78 citations · Full text

The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology

Vera Rebmann, Lisa König, Fabiola da Silva Nardi et al. · Frontiers in Immunology · 2016 · 64 citations · Full text

Histocompatibility, Hla Immunogenetics, Immunology +19

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

Lisa König, Fabian Mairinger, Oliver Hoffmann et al. · BMC Cancer · 2019 · 52 citations · Full text